Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenia and substance abuse

J A Selzer1, J A Lieberman

  • 1Department of Psychiatry, Albert Einstein College of Medicine, Bronx, New York.

The Psychiatric Clinics of North America
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.

Molecular psychiatry·2018
Same author

Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.

Psychological medicine·2017
Same author

Probable metronidazole induced serum sickness-like reaction in a paediatric patient.

Journal of clinical pharmacy and therapeutics·2016
Same author

The role of the ITIH3 rs2535629 variant in antipsychotic response.

Schizophrenia research·2016
Same author

Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.

The pharmacogenomics journal·2015
Same author

Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances.

Journal of psychiatric research·2014

Schizophrenia frequently co-occurs with substance abuse, complicating patient outcomes. Specialized psychiatric care is essential for managing these complex cases effectively.

Area of Science:

  • Psychiatry
  • Addiction Medicine
  • Clinical Psychology

Background:

  • Substantial comorbidity exists between schizophrenia and substance abuse disorders.
  • Substance abuse complicates the clinical course of schizophrenia.
  • Patients often report perceived benefits from substance use despite negative consequences.

Purpose of the Study:

  • To highlight the complex relationship between schizophrenia and substance abuse.
  • To emphasize the need for specialized treatment settings for dual-diagnosis patients.

Main Methods:

  • Literature review on schizophrenia and substance abuse comorbidity.
  • Analysis of patient-reported outcomes and clinical course data.

Main Results:

Related Experiment Videos

  • Substance abuse significantly complicates schizophrenia management.
  • Patients' perceived benefits from substance use present a treatment challenge.
  • High psychiatric expertise is crucial for effective intervention.

Conclusions:

  • Integrated treatment approaches are necessary for comorbid schizophrenia and substance abuse.
  • Treatment should occur in specialized psychiatric settings.
  • Addressing perceived benefits of substance use is key to successful management.